Skip to content
Wednesday, January 15, 2025
Canadian Stock Trader
Canadian Stocks
Search
Search
Home
Crypto
HeadLines
Stock News
Canadian Stock Trader
Home
Stock News
Kura Oncology Announces Publication of Ziftomenib Phase 1 Results in The Lancet Oncology
Stock News
Kura Oncology Announces Publication of Ziftomenib Phase 1 Results in The Lancet Oncology
September 30, 2024
Read More
Related
Post navigation
Alphabet executive John Kent Walker sells $2.78 million in stock
UBiqube Strengthens Board with Cloud and Security Veterans to Drive AgileOps Vision and Global Expansion